Table 1 Patient characteristics and baseline hormone measurements

N

21

16

24

19

14

Age (years)

30.7 (29.3–32.1)

41.6 (40.9–42.4)*

32.9 (31.8–34.1)

41.7 (41.0–42.4)*

31.4 (29.6–33.1)

BMI (kg/m²)

21.6^a (19.1–24.6)

23.5 (20.4–26.5)

20.8 (18.8–22.7)

24.0^a (21.9–26.3)

21.1 (17.7–24.4)

AMH (ng/mL)

7.7 (6.2–9.1)*

4.0 (3.3–4.8)*

0.4 (0.3–0.6)*

0.3^a (0.2–0.5)*

2.5 (2.0–3.0)

Total Testosterone (ng/dL)

44.0^a (32.9–58.7)*

27.8^a (21.8–35.5)

17.6^a (12.9–24.1)

18.1^a (13.6–24.1)

23.9^a (20.3–28.1)

Free Testosterone (pg/mL)

4.1 (2.2–5.9)*

1.5^a (1.0–2.2)

0.7^a (0.4–1.1)

1.4 (0.9–1.9)

1.6 (1.2–2.0)

DHEA (ng/dL)

398.8 (223.3–574.3)

269.6^a (205.1–354.4)

315.3 (223.3–407.3)

274.6^a (189.2–398.5)

302.8 (211.6–394.1)

DHEA-S (ug/dL)

236.6 (170.6–302.5)

183.9 (124.4–243.5)

130.6 (99.3–171.8)

158.5^a (117.1–214.5)

231.9 (157.3–306.4)

SHBG (nmol/L)

71.0 (26.7–115.2)

86.5 (56.9–116.1)

76.0^a (56.6–102.0)

65.6^a (50.4–85.4)

75.4^a (52.2–109.0)